Adjunct prednisone in community-acquired pneumonia: 180-day outcome of a multicentre, double-blind, randomized, placebo-controlled trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Adjunct prednisone in community-acquired pneumonia: 180-day outcome of a multicentre, double-blind, randomized, placebo-controlled trial ; volume:23 ; number:1 ; day:11 ; month:12 ; year:2023 ; pages:1-12 ; date:12.2023
BMC pulmonary medicine ; 23, Heft 1 (11.12.2023), 1-12, 12.2023
- Creator
-
Blum, Claudine A.
Roethlisberger, Eva A.
Cesana-Nigro, Nicole
Winzeler, Bettina
Rodondi, Nicolas
Blum, Manuel R.
Briel, Matthias
Mueller, Beat
Christ-Crain, Mirjam
Schuetz, Philipp
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12890-023-02794-w
- URN
-
urn:nbn:de:101:1-2024022614535136222826
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Blum, Claudine A.
- Roethlisberger, Eva A.
- Cesana-Nigro, Nicole
- Winzeler, Bettina
- Rodondi, Nicolas
- Blum, Manuel R.
- Briel, Matthias
- Mueller, Beat
- Christ-Crain, Mirjam
- Schuetz, Philipp
- SpringerLink (Online service)
Other Objects (12)
Childhood community-acquired pneumonia
Global trends in community-acquired pneumonia
Diagnostic error in community-acquired pneumonia
Modern treatment of community-acquired Pneumonia (CAP)
Non-infectious mimics of community-acquired pneumonia
Sex and gender differences in community-acquired pneumonia
Computed tomography in children with community-acquired pneumonia
Pharmacotherapy and the risk for community-acquired pneumonia
Community-Acquired Pneumonia in Children: Myths and Facts
Serum suPAR and syndecan-4 levels predict severity of community-acquired pneumonia: a prospective, multi-centre study
Identification of priority pathogens for aetiological diagnosis in adults with community-acquired pneumonia in China: a multicentre prospective study
Treatment of Community-Acquired Pneumonia: A Focus on Lefamulin
Childhood community-acquired pneumonia
Global trends in community-acquired pneumonia
Diagnostic error in community-acquired pneumonia
Modern treatment of community-acquired Pneumonia (CAP)
Non-infectious mimics of community-acquired pneumonia
Sex and gender differences in community-acquired pneumonia
Computed tomography in children with community-acquired pneumonia
Pharmacotherapy and the risk for community-acquired pneumonia
Community-Acquired Pneumonia in Children: Myths and Facts
Serum suPAR and syndecan-4 levels predict severity of community-acquired pneumonia: a prospective, multi-centre study
Identification of priority pathogens for aetiological diagnosis in adults with community-acquired pneumonia in China: a multicentre prospective study
Treatment of Community-Acquired Pneumonia: A Focus on Lefamulin
Childhood community-acquired pneumonia
Global trends in community-acquired pneumonia
Diagnostic error in community-acquired pneumonia
Modern treatment of community-acquired Pneumonia (CAP)
Non-infectious mimics of community-acquired pneumonia
Sex and gender differences in community-acquired pneumonia
Computed tomography in children with community-acquired pneumonia
Pharmacotherapy and the risk for community-acquired pneumonia
Community-Acquired Pneumonia in Children: Myths and Facts
Serum suPAR and syndecan-4 levels predict severity of community-acquired pneumonia: a prospective, multi-centre study
Identification of priority pathogens for aetiological diagnosis in adults with community-acquired pneumonia in China: a multicentre prospective study